Wockhardt Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Wockhardt Ltd. on BSE

Search Inside the pdf :

Wockhardt Ltd.

14 May 2025

1324.70

-2.52%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Pursuant to Regulation 32(6) of SEBI ( Listing Obligations & Disclosure Requirements) Regulations 2015, read with regulation 173 A of the SEBI (Issue of Capital & Disclosure Requirements) Regulations 2018, please find enclosed Monitoring Agency Reports towards utilisations of proceeds of the Qualified Institutions Placement ("QIPs") for the quarter ended 31st March, 2025 issued by CRISIL Ratings Limited duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.

pdf

Wockhardt Ltd.

11 Apr 2025

1324.70

-2.52%

Company Update

Wockhardt Ltd - 532300 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI ( Depositories and Participants ) Regulations , please find enclosed the Compliance Certificate received from MUFG Intime India Private Limited, Registrar and Transfer Agent of the Company for the quarter ended 31st March, 2025.

pdf

Wockhardt Ltd.

08 Apr 2025

1324.70

-2.52%

Company Update

Wockhardt Ltd - 532300 - Intimation For Incorporation Of A Step-Down Subsidiary Company

BSE India

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Wockhardt Bio AG, a subsidiary of the Company, has incorporated a new Wholly Owned Subsidiary in Ireland by the name Wockhardt Antibiotics (Ireland) Limited. Consequent to the Incorporation, Wockhardt Antibiotics (Ireland) Limited has become a Step- Down Subsidiary of the Company.

pdf

Wockhardt Ltd.

01 Apr 2025

1324.70

-2.52%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, please find enclosed Press Release - "Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with ZaynichTM (Zidebactam/Cefepime, WCK 5222)

pdf

Wockhardt Ltd.

27 Mar 2025

1324.70

-2.52%

SAST

Wockhardt Ltd - 532300 - Closure of Trading Window

BSE India

This is to inform you that pursuant to Company''s ''Code of Conduct for regulating, monitoring, and reporting trading by designated persons'' (''the Code''), the Trading Window for dealing in equity shares of the Company will be closed from 1st April, 2025 until 48 hours after the declaration of audited financial results of the Company for the financial year ended 31st March, 2025.

pdf

Wockhardt Ltd.

14 Feb 2025

1324.70

-2.52%

Company Update

WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025

pdf

Wockhardt Ltd.

14 Feb 2025

1324.70

-2.52%

Company Update

WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

We wish to inform you that the Share allotment Committee of the Board of Directors of the Company has allotted 13,250 equity shares of face value Rs. 5/- each on 14th February, 2025

pdf

Wockhardt Ltd.

07 Feb 2025

1324.70

-2.52%

Corp. Note

WOCKHARDT LTD. - 532300 - Integrated Filing (Financial)

BSE India

We are submitting herewith the Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.

pdf

Wockhardt Ltd.

07 Feb 2025

1324.70

-2.52%

Company Update

WOCKHARDT LTD. - 532300 - Statement On Deviation Or Variation Of Funds Raised Through Qualified Institutions …

BSE India

Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we hereby confirm that there has been no deviation in the utilisation of the issue proceeds from the object as stated in the Placement Documents dated 26th March 2024 and 11th November 2024 and accordingly, the Statements of Deviations in the prescribed format confirming Nil deviation duly reviewed by the Audit Committee are attached

pdf

Wockhardt Ltd.

07 Feb 2025

1324.70

-2.52%

Company Update

WOCKHARDT LTD. - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173(A) of the SEBI ( Issue of Capital and Disclosure Requirements) Regulations, 2018, please find attached Monitoring Agency Reports towards utilisation of proceeds of following Qualified institutions Placements ("QIPs") for the quarter ended 31st December, 2024 issued by CRISIL Rating Limited, duly reviewed and taken on record by Board of Directors & Audit Committee of the Company 1. QIP of Rs. 480.04 crore vide Placement Document dated 26.03.2024 (Annexure 1) 2. QIP of Approx. Rs. 1000 crore vide Placement Document dated 11.11.2024 (Annexure 2)

pdf

Is Wockhardt Ltd. worth buying?

443 Votes:

Buy 73.14%

Sell 17.38%

Hold 9.48%